Int Urol Nephrol. 2016 Nov;48(11):1777-1781 Autor: Girón-Prieto MS, Arias-Santiago S, Del Carmen Cano-García M, Poyatos-Andújar A, de Haro-Muñoz T, Abad-Menor F, Quesada-Charneco M, Arrabal-Polo MÁ, Arrabal-Martín M
J Bone Miner Metab. 2016 Nov;34(6):655-661.Watch Full Movie Online Streaming Online and Download Metabolic bone disease may appear as a complication of obesity surgery. These data show that the osteoprotegerin and receptor-activator of nuclear factor-κB … Leer más
Endocrinol Nutr. 2016 Nov;63(9):495-501. Autor: Botella Martínez S, Varo Cenarruzabeitia N, Escalada San Martin J, Calleja Canelas A.
Biochem Biophys Res Commun. 2016 Nov 28.Watch Full Movie Online Streaming Online and Download Reactive Oxygen Species (ROS) increase during aging, potentially affecting many tissues including brain, heart, and bone. ROS alter signaling pathways and … Leer más
Gynecol Endocrinol. 2016 Nov Breast cancer is the most prevalent cancer in women and presently. Over this issue Reviews the available evidence of the use of HT and tibolone in women treated for breast cancer. … Leer más
Osteoporos Int. 2016 Nov 12. Population with Down syndrome (DS) has lower areal BMD, in association with their smaller skeletal size. However, volumetric BMD and other indices of bone microarchitecture, such as trabecular bone score … Leer más
DOI: 10.5582/irdr.2016.01067 PMCID: PMC5116865 PMID: 27904825 Sclerosing bone dysplasias are a series of clinically and genetically heterogeneous diseases characterized by functional failure of the osteoclasts in bone resorption, leading to an excessive amount of bone … Leer más
Horm Metab Res. 2016 Nov 11. Autor: Díaz-Soto G, Romero E, Pérez-Castrillón JL, Jauregui OI, de Luis Román D
J Clin Endocrinol Metab. 2016 Nov;101(11):4125-4134 Specific serum miRNA profiles are strongly related to bone pathologies. Therefore miRNAs might be directly linked to bone tissue homeostasis. In particular, miR-29b-3p has previously been reported as regulator … Leer más
J Tissue Eng Regen Med. 2016 Nov 18. doi: 10.1002/term.2254 The use of multipotent mesenchymal stromal cells (MSCs) as candidate medicines for treating a variety of pathologies is based on their qualities as either progenitors … Leer más
